Dj Scisparc: Neurothera Labs Signs Non-Binding Term Sheet To Acquire 55% Equity Stake In A Quantum Algorithm Bio Data Analysis Co

(TheNewswire)

December 2, 2025 – TheNewswire - Vancouver,
British Columbia, Canada -  Neurothera Labs Inc. N (“Neurothera” or the “Company”), a clinical-stage
biotech company and a majority-owned subsidiary of SciSparc Ltd.
, today announced that it has entered into a non-binding
term sheet (the “TermSheet”) with a pioneering quantum computing bio data companyfocused on quantum-enabled clinical analytics (the “Target Company"). Under theterms of the Term Sheet, Neurothera will acquire a 55% equity interestin the Target Company, calculated on a post transaction fully dilutedbasis, from certain selling shareholders of the Target Company (the“Selling Shareholders”),in consideration for the issuance to the Selling Shareholders of thatamount of common shares in the capital of Neurothera (“CommonShares”) as is equal to 40% of the Common Shares, calculated on anon-diluted post transaction basis (the “Acquisition”).

By harnessing the principles of quantum computing, bio data can bestored, manipulated, and analyzed far more efficiently than existingtechnologies, potentially revolutionizing the field throughaccelerated processing and enhanced insights. This innovative approachis based on key quantum phenomena such as superposition, entanglement,and inherent parallelism to deliver faster computations and superiormachine learning performance. In turn, it strives to redefine clinicaltrials via quantum intelligence, seamlessly integrating quantumcomputing with bioinformatics and clinical data science to potentiallyunlock precision and speed in medical research and development.

Closing of the Acquisition remains subject to the completion of duediligence, negotiation and execution of definitive agreements, receiptof all required corporate and regulatory approvals, including that ofthe TSX Venture Exchange, and other customary closing conditions.There can be no assurance that any definitive agreement will beentered into or that the Acquisition will be completed on the termsdescribed, or at all.

About Neurothera Labs Inc.

Neurothera Labs Inc. N is a clinical-stage pharmaceutical
company focused on developing novel therapeutics for central nervous
system disorders and other underserved health conditions through
collaborations and innovative combinations.

For further information, please contact:

Michal Efraty IR Manager

Neurothera Labs Inc.

Telephone: 972-3-7617108

Email: michal@efraty.com

Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.

Cautionary NoteRegarding Forward-Looking Information

This press release contains“forward-looking statements” within the meaning of the securitieslaws. Words such as “expects,” “anticipates,” “intends,”“plans,” “believes,” “seeks,” “estimates” and similarexpressions or variations of such words are intended to identifyforward-looking statements. Forward-looking statements are nothistorical facts, and are based upon management’s currentexpectations, beliefs and projections, many of which, by their nature,are inherently uncertain. Such expectations, beliefs and projectionsare expressed in good faith. However, there can be no assurance thatmanagement’s expectations, beliefs and projections will be achieved,and actual results may differ materially from what is expressed in orindicated by the forward-looking statements. In addition, we cannotassure that any patent will be issued as a result of a pending patentapplication or, if issued, whether it will be issued in a form thatwill be advantageous to us. Forward-looking statements are subject torisks and uncertainties that could cause actual performance or resultsto differ materially from those expressed in the forward-lookingstatements. For a more detailed description of the risks anduncertainties affecting the Company, reference is made to theCompany’s reports filed from time to time at sedarplus.ca.Forward-looking statements speak only as of the date the statementsare made. The Company assumes no obligation to update forward-lookingstatements to reflect actual results, subsequent events orcircumstances, changes in assumptions or changes in other factorsaffecting forward-looking information except to the extent required byapplicable securities laws. If the Company does update one or moreforward-looking statements, no inference should be drawn that theCompany will make additional updates with respect thereto or withrespect to other forward-looking statements. References and links towebsites have been provided as a convenience, and the informationcontained on such websites is not incorporated by reference into thispress release. The Company is not responsible for the contents ofthird-party websites."

Copyright (c) 2025 TheNewswire - All rights reserved.